Group | Known IBD(%) | New IBD(%) | PUD(%) | NSI(%) | Cancer(%) | CRA(%) | Coeliac(%) | Unknown(%) | Other(%) |
---|---|---|---|---|---|---|---|---|---|
Age < 55 + FCP 60–100 (n = 15) | AB4 (26.7) | AB0 (0.0) | AB0 (0.0) | AB2 (13.3) | AB0 (0.0) | AB0 (0.0) | AB0 (0.0) | AB1 (6.7) | AB8 (53.3) |
Age < 55 + FCP > 100 (n = 68) | AB39 (57.4) | AB6 (8.8) | AB2 (2.9) | AB3 (4.4) | AB0 (0.0) | AB0 (0.0) | AB1 (1.5) | AB4 (5.9) | AB13 (19.1) |
Age > 55 + FCP 60–100 (n = 11) | AB3 (27.3) | AB0 (0.0) | AB0 (0.0) | AB0 (0.0) | AB0 (0.0) | AB1 (9.1) | AB0 (0.0) | AB0 (0.0) | AB7 (63.6) |
Age > 55 + FCP > 100 (n = 42) | AB22 (52.3) | AB2 (4.8) | AB0 (0.0) | AB0 (0.0) | AB2 (4.8) | AB2 (4.8) | AB0 (0.0) | AB2 (4.8) | AB12 (28.5) |